Skip to content

Clinical trials

Observational Hemorrhagic Stroke trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhagic Stroke Phase: Observational Country / region: China Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20161
20201
20223
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Unknown status4
Completed1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Hospital1
Beijing Tiantan Hospital1
Keuro MedTech1
Nanfang Hospital, Southern Medical University1
Second Affiliated Hospital, Zhejiang University, School of Medicine1
Shanghai 6th People's Hospital1
The University of Hong Kong1
Third Military Medical University1
Xiangya Hospital of Central South University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhagic Stroke9
Ischemic Stroke4
Cerebral Hemorrhage2
Stroke2
Atrial Fibrillation1
Embolic Stroke1
Embolism1
Hemorrhage1
Infarction, Anterior Cerebral Artery1
Infarction, Middle Cerebral Artery1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.